Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23737899 | 0.99 | CHEK2 (0.34) | CHEK2SIRT2SIRT1KDM4EALDH1A1 | |
| SCHEMBL25051593 | 0.97 | CHEK2 (0.36) | CHEK2SIRT2SIRT1KDM4EALDH1A1 | |
| SCHEMBL25049333 | 0.96 | CHEK2 (0.34) | CHEK2SIRT2SIRT1KDM4EALDH1A1 | |
| SCHEMBL23737898 | 0.95 | CHEK2 (0.33) | CHEK2SIRT2SIRT1 | |
| SCHEMBL23738583 | 0.95 | KDM4E (0.31) | KDM4ETSHR | |
| SCHEMBL23737419 | 0.95 | KDM4E (0.31) | KDM4ETSHR | |
| SCHEMBL23204080 | 0.95 | KDM4E (0.33) | KDM4EMAPTTSHR | |
| SCHEMBL23737882 | 0.94 | SIRT2 (0.34) | CHEK2SIRT2SIRT1KDM4E | |
| SCHEMBL25051123 | 0.94 | CHEK2 (0.35) | CHEK2 | |
| SCHEMBL25051118 | 0.94 | CHEK2 (0.35) | CHEK2SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, ELOVL1, CRY1 | CHEK2 2378/4885SIRT2 353/4885SIRT1 576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.